Hybrigenics Services
Director, Business Development North America
Who are we?
HYBRIGENICS SERVICES is a leading provider of innovative technologies to:
• discover direct drug-protein and protein-protein interactions in any organism, tissue or cell type. Our proprietary, highly sensitive method allows to decipher drugs’ mechanism of action, to reposition drugs in new indications by discovering additional targets and to assess putative side effects/toxicity.
• select original single domains antibodies against soluble and cell surface antigens from a patented library of 3x10E9 synthetic, llama-derived VHH.
Over 2,000 investigators in major pharmaceutical and agrobiotech companies and universities across the world have trusted us with their projects and benefited from our expertise.